Status:
COMPLETED
Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will evaluate the potential effect of CP 690,550 on the pharmacokinetics of metformin, a probe drug for organic cationic transport.
Eligibility Criteria
Inclusion
- Adult healthy male and/or female (of non child bearing potential) subjects.
Exclusion
- Subjects with clinically significant systemic and laboratory abnormalities.
- Subjects with clinically significant infections within the past 3 months.
- Women of child-bearing potential.
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01405118
Start Date
June 1 2011
End Date
July 1 2011
Last Update
August 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Brussels, Belgium, B-1070